Stephen D. Ryder

Nottingham Digestive Diseases Centre
University of Nottingham
Nottingham United Kingdom NG7 2UH

Papers:
4K-6 WHEN AND WHERE IN THE TREATMENT PATHWAY IS IT APPROPRIATE TO USE NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C?